4
Changes in Ownership
Damora Therapeutics, Inc. Filed Acc 0000950170-25-094575
General Counsel sold 260 shares at $3.39 ($881)
- General Counsel acquired 680 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Winslow Garrett General Counsel | 2025-07-03 | Option exercise | +680 | 1,689 | D | ||
| Winslow Garrett General Counsel | 2025-07-03 | Sale | −260 | $3.39 | $881 | 1,429 | D |
| Derivatives | |||||||
| Winslow Garrett General Counsel | 2025-07-03 | Option exercise · Restricted Stock Units | −680 | 2,000 | D | ||
| Open-market sales · 260 sh · avg $3.39 · $881 | |||||||
Loading xslF345X05/ownership.xml…